Literature DB >> 14717585

Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods.

Reza Khayat1, Renu Batra, Geraldine A Bebernitz, Matthew W Olson, Liang Tong.   

Abstract

Herpesviruses encode a serine protease that is essential for the maturation of infectious virions. This protease has a unique polypeptide backbone fold and contains a novel Ser-His-His catalytic triad. It exists in a monomer-dimer equilibrium in solution, but only the dimer form of the enzyme is catalytically active. The stability of this dimer is affected by the presence of anti-chaotropic agents. Most of the reported Kd values for this dimer (between 0.6 and 6 microM) are inconsistent with the fact that the protease is routinely assayed at 20-50 nM concentrations, as only monomeric species would be expected with such Kd values. We have characterized the monomer-dimer equilibrium of HCMV protease using a new method, which observes the exchange between dimers of the wild-type enzyme and the active-site Ser132Ala mutant in a titration experiment. The Kd of the dimer was determined to be 8 microM and 31 nM in the absence or presence of anti-chaotropic agents (10% glycerol and 0.5 M Na2SO4), respectively. Detailed kinetic analysis also showed that, in addition to the 260-fold stabilization of the dimer, the anti-chaotropic agents produced a 7-fold enhancement in the catalytic activity of the dimer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14717585     DOI: 10.1021/bi035170d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Experimental and simulative dissociation of dimeric Cu,Zn superoxide dismutase doubly mutated at the intersubunit surface.

Authors:  L Maragliano; M Falconi; A Sergi; P Cioni; S Castelli; A Lania; M E Stroppolo; G Strambini; M Ferrario; A Desideri
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

2.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 4.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

5.  Herpesvirus protease inhibition by dimer disruption.

Authors:  Nobuhisa Shimba; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Understanding the role of water on temperature-dependent structural modifications of SARS CoV-2 main protease binding sites.

Authors:  Pushyaraga P Venugopal; Omkar Singh; Debashree Chakraborty
Journal:  J Mol Liq       Date:  2022-07-20       Impact factor: 6.633

7.  Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.

Authors:  Chih-Jung Kuo; Ya-Hui Chi; John T-A Hsu; Po-Huang Liang
Journal:  Biochem Biophys Res Commun       Date:  2004-06-11       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.